799-2347483-0/10002/1

Abbvie Biotechnology Gmbh — FEI 3011277200

Refusal Details

Date
January 27, 2026
Country
Germany
Product Category
Drugs and Biologics
Product Code
58SCK14 ADALIMUMAB
Charges
75